Free Submission Public Relations & NewsPR-inside.com
Home
Deutsch English

Business

Cryo-Save Group N.V. - Share buyback tranche successfully completed


Print article Print article
Copyright © Thomson Reuters 2013. All rights reserved.
2013-01-31 13:25:35 -

Cryo-Save Group N.V. (Euronext: CRYO, 'Cryo-Save', or 'the Group'), the
leading
international stem cell storage company and the largest family stem cell bank in
Europe, announces that it has completed the tranche of its share buyback
programme as announced on 30 January 2013.

The Group has purchased 1,597 shares and has reached an agreement with a
shareholder regarding the buyback of 120,000 shares via its bank Kempen & Co.
The share purchase and the block trade are part of the share buyback programme
as announced yesterday. Cryo-Save repurchased these 121,597 shares at an average
price of € 2.34.

These shares together with the 364,000 treasury shares that are already in the
possession of the Group, representing 5% of the issued shares, will be proposed
for cancellation by the Board at the upcoming 
Annual General Meeting on 15 May 2013. Enquiries: Cryo-Save Group, Arnoud van Tulder, Chief Executive Officer + 31 (0) 575 509 100 Please click here for full press release in PDF: hugin.info/143308/R/1674596/545320.pdf This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients. The owner of this announcement warrants that: (i) the releases contained herein are protected by copyright and other applicable laws; and (ii) they are solely responsible for the content, accuracy and originality of the information contained therein. Source: Cryo-Save Group N.V. via Thomson Reuters ONE [HUG#1674596]


Press Information:




Contact Person:


Disclaimer: © 2014 Thomson Reuters. The press releases or report contained herein is protected by copyright and other applicable laws, treaties and conventions. Information contained in the releases is furnished by Thomson Reuters's, who warrant that they are solely responsible for the content, accuracy and originality of the information contained therein. All reproduction, other than for an individual user's personal reference, is prohibited without prior written permission.
Latest News
Read the Latest News
www.newsenvoy.com

 


Terms & Conditions | Privacy | About us | Contact PR-inside.com | BidVertiser